Fintel reports that on February 5, 2025, Piper Sandler upgraded their outlook for Simon Property Group, Inc. - Preferred ...

Piper Sandler raised the firm’s price target on Kemper (KMPR) to $86 from $83 and keeps an Overweight rating on the shares following quarterly ...

Fintel reports that on February 5, 2025, Piper Sandler initiated coverage of Opera Limited - Depositary Receipt () ...

Piper Sandler restated their neutral rating on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a research report ...

Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...

Piper Sandler's research dated Feb. 4 has revealed a less optimistic outlook for Meta Platforms' position in the artificial intelligence race.

Piper Sandler restated their overweight rating on shares of The Cigna Group (NYSE:CI – Free Report) in a research note published on Monday morning,Benzinga reports. Piper Sandler currently has a $348.

In a report released today, David Amsellem from Piper Sandler maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report), with ...

He noted that advisory services accounted for over half of firmwide net revenues for the fourth consecutive year. Abraham stated that the company completed the acquisition of Aviditi Advisors, ...

Investing.com -- Piper Sandler analysts see Tesla (NASDAQ: TSLA) as "one of the most defensive stocks" in the auto sector ...